Bioresorbable scaffolds promise to counteract late thrombosis by the absence of residual foreign material over time and the restoration of functional endothelial coverage. However, although currently available data are controversial, initial post-marketing studies have raised some concerns about the putative increased early thrombogenicity of bioresorbable scaffolds as compared to currently available second-generation drug-eluting stents. This article focuses on incidence rates, putative mechanisms and prevention strategies of scaffold thrombosis.
What about the risk of thrombosis with bioresorbable scaffolds?
CAPODANNO, DAVIDE FRANCESCO MARIA;
2015-01-01
Abstract
Bioresorbable scaffolds promise to counteract late thrombosis by the absence of residual foreign material over time and the restoration of functional endothelial coverage. However, although currently available data are controversial, initial post-marketing studies have raised some concerns about the putative increased early thrombogenicity of bioresorbable scaffolds as compared to currently available second-generation drug-eluting stents. This article focuses on incidence rates, putative mechanisms and prevention strategies of scaffold thrombosis.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
what-about-the-risk-of-thrombosis-with-bioresorbable-scaffolds.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
636.43 kB
Formato
Adobe PDF
|
636.43 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.